Menu
View Cart  

Pharmacovigilance in the European Union: A Guide to New Directives

$397.00
Quantity Discounts
1 - 2
$397.00		3 - 4
$357.00		5 - 6
$337.00		7 - 9
$317.00		10 - 9999
$297.00
Navigating EU pharmacovigilance requirements is a complex task that starts in the early stages of drug development and extends right through the drug's life.

In order to stay compliant in the EU’s complicated regulatory environment drugmakers must know:

  • How to gain and renew “Marketing Authorization Holder” (MAH) status
  • The role of the Pharmacovigilance Risk Assessment Committee (PRAC) in monitoring and auditing manufacturers and enforcing the pharmacovigilance rules
  • What kinds of surveillance efforts the EU expects

This report, Pharmacovigilance in the European Union, will help readers navigate the EU’s regulatory landscape by covering the following issues:

  • Periodic Safety Update Reports — what they must contain, and how frequently they must be issued

  • Marketing authorization — the difference between getting it and renewing it

  • The new rules on post-authorization efficacy studies

  • The powers of the Pharmacovigilance Risk Assessment Committee and their relationship with the Committee on Human Medicinal Products

  • The significance of the “Black Triangle”

Order Pharmacovigilance in the European Union and stay on top of the most recent EU pharmacovigilance directives.

Order Your Copy Today!

PDF Edition

Available Format

PDF Edition — $397

Who Will Benefit

  • Auditors
  • Compliance officers
  • Consultants/service providers
  • Data management and statistics personnel
  • Executive management
  • General/corporate counsel
  • Investigators
  • Managers
  • Manufacturing directors and supervisors
  • Personnel new to the industry
  • Pharmaceutical and cGMP auditors
  • Regulatory/legislative affairs professionals
  • Risk management specialists
  • Strategic planning and business development staff

Multi-user Access

Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library – a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.

Our Guarantee

Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

Related Products

Surviving the New FDA Inspection Plan: A Drugmaker’s Guide to Working with the Agency

Search the Store

Shop by Category

Shop by Media